Cellectis S.A. ( CMVLF) - Key Metrics
Stock symbol CMVLF is outdated, potentially delisted? Maybe it is available on other exchange?
CMVLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.10 | -$0.26 | -$0.11 | -$0.11 |
| 2025Q3 | $0.35 | $0.01 | -$0.02 | -$0.03 |
| 2025Q2 | $0.17 | -$0.24 | -$0.10 | -$0.11 |
| 2025Q1 | $0.11 | -$0.18 | -$0.17 | -$0.18 |
| 2024Q4 | $0.14 | $0.07 | $0 | -$0.02 |
CMVLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -4.66 |
| 2025Q3 | ? | 117.92 |
| 2025Q2 | ? | -1.59 |
| 2025Q1 | ? | -1.79 |
| 2024Q4 | ? | 6.40 |
CMVLF
Price: $4.50
52 week price:
Earnings Per Share: -0.67 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 452.7 million